focus -WSS

focus

author：hotspot 2025-09-27 19:37:07 - browse：1

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Ozempic cut risk of death in diabetes patients with chronic kidney disease

WSS

Influencer to be charged after chaos erupts in New York City's Union Square

A cyberattack has disrupted hospitals and health care in several states

Some medical students still think black patients feel less pain

White House drug shortage group privately met with industry

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

OTC birth control: A brief history of over the counter pill design

focus

focus

hotspot

Sports medicine is finally prioritizing gender equality

What Mike Pence has said that could be used in a Donald Trump trial

United colonoscopy coverage change 'may cost lives,' doctors say

Gilgo Beach: Police identify another victim in serial killing investigation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

As demand for Covid shots wanes, Moderna seeks its next success

Achieving telehealth equity for people with hearing loss

23andMe had bad news about my health. I wish a person had delivered it

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

focus

2 US Navy sailors arrested for allegedly spying for China

J&J reports mixed data on next

The Bio Revolution is changing business and society

Louisiana bill approved classifying abortion pills as controlled substances

What the cancer research community can learn from the Covid response

Gilgo Beach: Police identify another victim in serial killing investigation

explore

knowledge

hotspot

entertainment